Self-Testing Market is Estimated to Witness High Growth Owing to Rising Adoption of Home Diagnostics

Self-Testing Market The self-testing market involves home-based diagnostic tests that allow individuals to collect samples independently and interpret results without the involvement of healthcare professionals. Some common types of self-testing kits available are blood glucose monitoring, pregnancy, ovulation, cholesterol, HIV, and drugs of abuse testing kits. Self-testing kits offer privacy, convenience, and faster results compared to laboratory tests. The growing awareness about early disease detection and management is driving the demand for self-monitoring of health parameters through home use kits. Global self-testing market is estimated to be valued at US$ 25,191.62 million in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the self-testing market are BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, am...